These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12869834)

  • 21. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
    Banas B; Kost BP; Goebel FD
    Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
    van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P
    Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.
    de Mendoza C; Sánchez-Conde M; Timmermans E; Buitelaar M; de Baar MP; Gonzalez-Lahoz J; Soriano V
    Antivir Ther; 2005; 10(4):557-61. PubMed ID: 16038482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
    Zhang H; Cooney DA; Sreenath A; Zhan Q; Agbaria R; Stowe EE; Fornace AJ; Johns DG
    Mol Pharmacol; 1994 Dec; 46(6):1063-9. PubMed ID: 7808425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
    Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between the change regularity of peripheral blood mononuclear cell mitochondrial deoxyribonucleic acid content and human immunodeficiency virus-related lipodystrophy].
    Wu P; Gu WB; Zhang L; Li YL; Qiu ZF; Han Y; Xie J; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1448-52. PubMed ID: 21914278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
    Miró O; Villarroya J; Garrabou G; López S; Rodríguez de la Concepción M; Pedrol E; Martínez E; Giralt M; Gatell JM; Cardellach F; Casademont J; Villarroya F
    Antivir Ther; 2005; 10(8):945-51. PubMed ID: 16430200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
    Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
    AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.
    Einsiedel L; Cherry CL; Sheeran FL; Friedhuber A; Wesselingh SL; Pepe S
    Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
    McComsey GA; Kang M; Ross AC; Lebrecht D; Livingston E; Melvin A; Hitti J; Cohn SE; Walker UA;
    HIV Clin Trials; 2008; 9(2):126-36. PubMed ID: 18474497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat.
    Cherry CL; Gahan ME; McArthur JC; Lewin SR; Hoy JF; Wesselingh SL
    J Acquir Immune Defic Syndr; 2002 Jul; 30(3):271-7. PubMed ID: 12131563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
    Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
    Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.
    Divi RL; Walker VE; Wade NA; Nagashima K; Seilkop SK; Adams ME; Nesel CJ; O'Neill JP; Abrams EJ; Poirier MC
    AIDS; 2004 Apr; 18(7):1013-21. PubMed ID: 15096804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
    Poirier MC; Divi RL; Al-Harthi L; Olivero OA; Nguyen V; Walker B; Landay AL; Walker VE; Charurat M; Blattner WA;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):175-83. PubMed ID: 12794551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
    Squires KE; Gulick R; Tebas P; Santana J; Mulanovich V; Clark R; Yangco B; Marlowe SI; Wright D; Cohen C; Cooley T; Mauney J; Uffelman K; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1591-600. PubMed ID: 10983646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.